Amphotericin B (Lipid Formulations)

Treatment for Meningitis

Typical Dosage: 3-5 mg/kg IV daily

Effectiveness
80%
Safety Score
35%
Clinical Trials
100
Participants
10K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
35
DangerousModerateSafe
Treatment Details
Dosage Range
3-5 mg/kg IV daily
Time to Effect
days to weeks
Treatment Duration
weeks to months
Evidence Quality
HIGH
Number Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
8(Treat 8 patients to see 1 additional serious adverse event)
Confidence Score
88%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$10,000
Monitoring:$4,000
Side Effect Mgmt:$1,500
Total Annual:$15,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
QALYs Gained
6
Outcome-Based Costs
Cost per Responder
$22,143
Cost per Remission
$26,724
Amphotericin B (Lipid Formulations) Outcomes

for Meningitis

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+70%
Remission Rate
+58%
Common Side Effects
Nephrotoxicity
+20%
Infusion-related reactions
+35%
Electrolyte abnormalities
+30%

Sources:

researchgate.net
researchgate.net
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov